UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 1/2013, Volume 56, Issue 2, pp. 236 - 244
Intensive care units | Control groups | Beta lactams | Antibiotics | Boluses | Critical care | Sepsis | Hospital units | Infections | ARTICLES AND COMMENTARIES | Blood plasma | meropenem | pharmacokinetics | ticarcillin-clavulanate | clinical outcome | piperacillin-tazobactam | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Bacterial sepsis | Antibiotics. Antiinfectious agents. Antiparasitic agents | beta-Lactams - pharmacokinetics | Humans | Middle Aged | Male | Treatment Outcome | Sepsis - mortality | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Anti-Bacterial Agents - pharmacokinetics | beta-Lactams - adverse effects | Adult | Female | Aged | Anti-Bacterial Agents - adverse effects | Infusions, Intravenous | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | Sepsis - microbiology | beta-Lactams - administration & dosage | Care and treatment | Demographic aspects | Beta lactam antibiotics | Dosage and administration | Research | Pharmacokinetics | Clinical trials | Pharmacology | Drug therapy | Drug dosages | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 8/2015, Volume 61, Issue 3, pp. 361 - 367
ARTICLES AND COMMENTARIES | MSSA | vancomycin | beta-lactams | bloodstream infection | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Staphylococcal Infections - drug therapy | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Middle Aged | Male | Cross Infection - drug therapy | Vancomycin - adverse effects | Anti-Bacterial Agents - therapeutic use | beta-Lactams - pharmacology | Staphylococcal Infections - epidemiology | Vancomycin - therapeutic use | Cross Infection - microbiology | Vancomycin - pharmacology | beta-Lactams - adverse effects | Female | Aged | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - pharmacology | Staphylococcal Infections - microbiology | beta-Lactams - therapeutic use | Cross Infection - epidemiology | Treatment outcome | Care and treatment | Analysis | Beta lactam antibiotics | Dosage and administration | Vancomycin | Comparative analysis | Bacteremia | Staphylococcus infections | Antibiotics | Blood diseases | Drug therapy | Patients | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2005, Volume 352, Issue 4, pp. 380 - 391
Biological and medical sciences | General aspects | Medical sciences | Humans | Molecular Conformation | Risk Factors | Gram-Negative Bacterial Infections - drug therapy | Gram-Negative Bacteria - enzymology | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | beta-Lactamases - chemistry | beta-Lactams - pharmacology | beta-Lactamases - classification | beta-Lactamases - genetics | Gram-Negative Bacterial Infections - epidemiology | Disease Outbreaks - prevention & control | Anti-Bacterial Agents - pharmacology | beta-Lactam Resistance - genetics | beta-Lactams - therapeutic use | beta-Lactam Resistance - physiology | Beta lactam antibiotics | Research | Index Medicus | Abridged Index Medicus
Journal Article
Chemical reviews, ISSN 0009-2665, 02/2005, Volume 105, Issue 2, pp. 395 - 424
Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | beta-Lactams - metabolism | beta-Lactam Resistance | Models, Molecular | Anti-Bacterial Agents - metabolism | Cell Wall - enzymology | beta-Lactams - chemistry | beta-Lactams - pharmacology | Cell Wall - drug effects | Anti-Bacterial Agents - chemistry | Cell Wall - metabolism | Protein Binding | Anti-Bacterial Agents - pharmacology | Bacterial Proteins - biosynthesis | Molecular Structure | beta-Lactamases - metabolism | Drug resistance | Bacteria | Index Medicus
Journal Article
Microbial drug resistance (Larchmont, N.Y.), ISSN 1076-6294, 07/2016, Volume 22, Issue 5, pp. 399 - 403
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Skin - microbiology | Virulence Factors - genetics | Escherichia coli - drug effects | Humans | Male | Phylogeny | Cross Infection - transmission | Microbial Sensitivity Tests | beta-Lactamases - genetics | Polymerase Chain Reaction | Female | Tunisia | Fomites - microbiology | Integrons | Gene Expression | Escherichia coli Infections - microbiology | Electrophoresis, Gel, Pulsed-Field | Plasmids - metabolism | Sequence Analysis, DNA | beta-Lactams - pharmacology | Hospitals | Escherichia coli - genetics | Escherichia coli - isolation & purification | Cross Infection - microbiology | Escherichia coli Infections - transmission | Plasmids - chemistry | Anti-Bacterial Agents - pharmacology | beta-Lactam Resistance - genetics | Escherichia coli - classification | E coli | Multidrug resistant organisms
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 04/2017, Volume 61, Issue 4
Inhibitors | Beta-lactams | Antibiotic resistance | Beta-lactamases | Boronate | Carbapenemase | Metalloenzymes | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Enterobacteriaceae - enzymology | Bacterial Proteins - chemistry | Substrate Specificity | Crystallography, X-Ray | Thermodynamics | beta-Lactamases - genetics | Cloning, Molecular | Escherichia coli - metabolism | Protein Interaction Domains and Motifs | beta-Lactamases - metabolism | Binding Sites | Boronic Acids - chemical synthesis | Enterobacteriaceae - growth & development | Recombinant Proteins - metabolism | Bacterial Proteins - antagonists & inhibitors | Gene Expression | Protein Structure, Secondary | Bacterial Proteins - genetics | Enterobacteriaceae - genetics | Models, Molecular | Recombinant Proteins - chemistry | Recombinant Proteins - genetics | beta-Lactamase Inhibitors - pharmacology | Amino Acid Motifs | Anti-Bacterial Agents - chemical synthesis | beta-Lactamases - chemistry | beta-Lactams - pharmacology | Cyclization | Escherichia coli - genetics | Enterobacteriaceae - drug effects | beta-Lactamase Inhibitors - chemical synthesis | Protein Binding | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | beta-Lactam Resistance - genetics | Kinetics | Boronic Acids - pharmacology | beta-Lactam Resistance - drug effects | Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2011, Volume 66, Issue 4, pp. 689 - 692
Metallo-β-Lactamases | Pakistan | Carbapenemases | Enterobacteriaceae | India | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Klebsiella pneumoniae - isolation & purification | beta-Lactam Resistance | Klebsiella pneumoniae - drug effects | Pandemics | Escherichia coli - drug effects | Humans | Infection Control - methods | beta-Lactamases - biosynthesis | Mass Screening - methods | Disease Transmission, Infectious - prevention & control | Klebsiella Infections - epidemiology | Pakistan - epidemiology | Communicable Diseases, Emerging - drug therapy | Escherichia coli Infections - drug therapy | Communicable Diseases, Emerging - microbiology | Escherichia coli - enzymology | Klebsiella Infections - drug therapy | Escherichia coli Infections - microbiology | India - epidemiology | Communicable Diseases, Emerging - epidemiology | Klebsiella Infections - microbiology | Sweden - epidemiology | Escherichia coli Infections - epidemiology | beta-Lactams - pharmacology | Escherichia coli - isolation & purification | Klebsiella pneumoniae - enzymology | beta-Lactams - therapeutic use | United Kingdom - epidemiology | Index Medicus | Infection | Antibiotics | Multidrug resistance | Aztreonam | Gram-negative bacteria | Metallo- beta -lactamase | Hygiene | beta -Lactam antibiotics
Journal Article
Journal of Clinical Microbiology, ISSN 0095-1137, 03/2012, Volume 50, Issue 3, pp. 927 - 937
Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | beta-Lactams - metabolism | beta-Lactam Resistance | Time Factors | Anti-Bacterial Agents - chemistry | Sensitivity and Specificity | Anti-Bacterial Agents - metabolism | Bacteria - enzymology | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Microbial Sensitivity Tests - methods | beta-Lactams - chemistry | Index Medicus | Bacteriology
Journal Article